CareTrust REIT experienced explosive growth with net income surging 156% to $320.5M while doubling debt to $894.2M, indicating either major acquisitions or significant operational expansion.
The dramatic financial metrics suggest CareTrust executed a major growth strategy, likely through substantial property acquisitions given the 49.8% asset increase and 19% rise in outstanding shares (from 187.7M to 223.4M shares). However, the 125% debt increase significantly outpaced equity growth of 38.7%, materially changing the company's leverage profile and potentially increasing financial risk.
CareTrust delivered exceptional financial performance with revenue growing 61% to $476.4M and net income more than doubling to $320.5M, while operating cash flow increased 61% to $394.0M, demonstrating strong operational execution. However, the company dramatically increased its leverage with total debt surging 125% to $894.2M, far outpacing the 39% growth in stockholders' equity to $4.0B. The overall picture suggests aggressive expansion financing through debt and equity issuance (19% share increase) that delivered strong returns but materially altered the balance sheet risk profile.
Net income grew 156.3% — bottom-line growth signals improving overall business health.
Debt increased 125.3% — substantial leverage increase; assess whether deployed for growth or covering losses.
Liabilities grew 114.6% — significant increase in debt or obligations, assess impact on financial flexibility.
Capital expenditure jumped 64.8% — major investment cycle underway; assess returns on deployment.
Operating cash flow surged 61.3% — exceptional cash generation, highest quality earnings signal.
Strong top-line growth of 60.8% — accelerating demand or successful expansion into new markets.
Asset base grew 49.8% — expansion through organic growth, acquisitions, or capital deployment.
Interest expense surged 44.2% — significant debt increase or rising rates materially impacting earnings.
Equity base grew 38.7% — retained earnings accumulation or equity issuance strengthening the balance sheet.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →